Repligen (RGEN) Price to Sales (2010 - 2026)

Repligen (RGEN) has reported Price to Sales for 17 consecutive years, with 37.72 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales fell 1.7% year-over-year to 37.72 in Q2 2026; TTM through Jun 2026 was 9.81, a 5.54% decrease from a year earlier, with the FY2025 full-year figure at 12.5, down 1.76% from the prior year.
• Price to Sales was 37.72 for Q2 2026 at Repligen, up from 34.21 in the prior quarter.
• Over five years, Price to Sales peaked at 67.05 in Q1 2024 and troughed at 34.21 in Q1 2026.
• A 5-year average of 48.76 and a median of 48.87 in 2023 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales tumbled 42.27% in 2022 and rose 21.38% in 2023, its largest moves.
• Over 5 years, Price to Sales stood at 50.37 in 2022, then grew by 19.48% to 60.18 in 2023, then decreased by 19.92% to 48.19 in 2024, then retreated by 3.23% to 46.63 in 2025, then dropped by 19.12% to 37.72 in 2026.
• The last three Price to Sales figures came in at 37.72 (Q2 2026), 34.21 (Q1 2026), and 46.63 (Q4 2025), per Business Quant data.